This company listing is no longer active
Satsuma Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Satsuma Pharmaceuticals has a total shareholder equity of $37.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $43.5M and $5.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$41.37m |
Equity | US$37.65m |
Total liabilities | US$5.83m |
Total assets | US$43.48m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1LV's short term assets ($43.4M) exceed its short term liabilities ($5.8M).
Long Term Liabilities: 1LV has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 1LV is debt free.
Reducing Debt: 1LV currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 1LV has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 1LV has less than a year of cash runway if free cash flow continues to reduce at historical rates of 27.4% each year